Bone metabolism in children with human immunodeficiency virus infection receiving highly active anti-retroviral therapy including a protease inhibitor

Belen M. Tan, Robert Nelson, Michelle James-Yarish, Patricia J. Emmanuel, Scott J. Schurman

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

We measured serum osteocalcin levels in prepubertal children with human immunodeficiency virus (HIV) infection receiving highly active antiretroviral therapy including a protease inhibitor and uninfected control children. Osteocalcin values were significantly elevated in the HIV-infected patients. Though osteocalcin serves as an index of bone formation, it likely functions as a negative regulator of bone formation. Further study is necessary to determine whether protease inhibitors normalize bone physiology or decrease bone formation and reduce bone mineral density in children receiving these therapies.

Original languageEnglish (US)
Pages (from-to)447-451
Number of pages5
JournalJournal of Pediatrics
Volume139
Issue number3
DOIs
StatePublished - 2001

Fingerprint

Osteocalcin
Virus Diseases
Protease Inhibitors
Osteogenesis
HIV
Bone and Bones
Highly Active Antiretroviral Therapy
Bone Density
Therapeutics
Serum

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Bone metabolism in children with human immunodeficiency virus infection receiving highly active anti-retroviral therapy including a protease inhibitor. / Tan, Belen M.; Nelson, Robert; James-Yarish, Michelle; Emmanuel, Patricia J.; Schurman, Scott J.

In: Journal of Pediatrics, Vol. 139, No. 3, 2001, p. 447-451.

Research output: Contribution to journalArticle

Tan, Belen M. ; Nelson, Robert ; James-Yarish, Michelle ; Emmanuel, Patricia J. ; Schurman, Scott J. / Bone metabolism in children with human immunodeficiency virus infection receiving highly active anti-retroviral therapy including a protease inhibitor. In: Journal of Pediatrics. 2001 ; Vol. 139, No. 3. pp. 447-451.
@article{0b79a73a06504e199a3deba6537a342a,
title = "Bone metabolism in children with human immunodeficiency virus infection receiving highly active anti-retroviral therapy including a protease inhibitor",
abstract = "We measured serum osteocalcin levels in prepubertal children with human immunodeficiency virus (HIV) infection receiving highly active antiretroviral therapy including a protease inhibitor and uninfected control children. Osteocalcin values were significantly elevated in the HIV-infected patients. Though osteocalcin serves as an index of bone formation, it likely functions as a negative regulator of bone formation. Further study is necessary to determine whether protease inhibitors normalize bone physiology or decrease bone formation and reduce bone mineral density in children receiving these therapies.",
author = "Tan, {Belen M.} and Robert Nelson and Michelle James-Yarish and Emmanuel, {Patricia J.} and Schurman, {Scott J.}",
year = "2001",
doi = "10.1067/mpd.2001.117005",
language = "English (US)",
volume = "139",
pages = "447--451",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Bone metabolism in children with human immunodeficiency virus infection receiving highly active anti-retroviral therapy including a protease inhibitor

AU - Tan, Belen M.

AU - Nelson, Robert

AU - James-Yarish, Michelle

AU - Emmanuel, Patricia J.

AU - Schurman, Scott J.

PY - 2001

Y1 - 2001

N2 - We measured serum osteocalcin levels in prepubertal children with human immunodeficiency virus (HIV) infection receiving highly active antiretroviral therapy including a protease inhibitor and uninfected control children. Osteocalcin values were significantly elevated in the HIV-infected patients. Though osteocalcin serves as an index of bone formation, it likely functions as a negative regulator of bone formation. Further study is necessary to determine whether protease inhibitors normalize bone physiology or decrease bone formation and reduce bone mineral density in children receiving these therapies.

AB - We measured serum osteocalcin levels in prepubertal children with human immunodeficiency virus (HIV) infection receiving highly active antiretroviral therapy including a protease inhibitor and uninfected control children. Osteocalcin values were significantly elevated in the HIV-infected patients. Though osteocalcin serves as an index of bone formation, it likely functions as a negative regulator of bone formation. Further study is necessary to determine whether protease inhibitors normalize bone physiology or decrease bone formation and reduce bone mineral density in children receiving these therapies.

UR - http://www.scopus.com/inward/record.url?scp=0034826780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034826780&partnerID=8YFLogxK

U2 - 10.1067/mpd.2001.117005

DO - 10.1067/mpd.2001.117005

M3 - Article

C2 - 11562628

AN - SCOPUS:0034826780

VL - 139

SP - 447

EP - 451

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 3

ER -